Domenico Inzitari1. 1. Department of Neurological and Psychiatric Sciences, University of Florence, Viale Morgagni 85, 50134 Florence, Italy. inzitari@neuro.unifi.it
Abstract
BACKGROUND: Leukoaraiosis, a term that defines an abnormal appearance of the subcortical white matter of the brain on neuroimaging (bilateral patchy or diffuse areas of low attenuation on CT or hyperintense T2 MR areas), has gained evidence in retrospective studies to demonstrate its association with stroke and in prospective studies to demonstrate its prognostic value related to the occurrence of stroke, both ischemic and hemorrhagic, or the occurrence of vascular death. SUMMARY OF REVIEW: The subtype of ischemic stroke most strongly predicted by leukoaraiosis is lacunar infarct, which is likely caused by the same underlying small-vessel pathology. Leukoaraiosis has been shown to predispose to intracerebral hemorrhage at both the basal-ganglionic and lobar sites, primarily when leukoaraiosis is extensive and patients are treated with anticoagulants because of prior ischemic events. CONCLUSIONS: Leukoaraiosis shares with stroke common pathophysiological mechanisms and, because it is likely an expression of the same disease, must be regarded as an intermediate surrogate of stroke rather than a true stroke risk factor.
BACKGROUND:Leukoaraiosis, a term that defines an abnormal appearance of the subcortical white matter of the brain on neuroimaging (bilateral patchy or diffuse areas of low attenuation on CT or hyperintense T2 MR areas), has gained evidence in retrospective studies to demonstrate its association with stroke and in prospective studies to demonstrate its prognostic value related to the occurrence of stroke, both ischemic and hemorrhagic, or the occurrence of vascular death. SUMMARY OF REVIEW: The subtype of ischemic stroke most strongly predicted by leukoaraiosis is lacunar infarct, which is likely caused by the same underlying small-vessel pathology. Leukoaraiosis has been shown to predispose to intracerebral hemorrhage at both the basal-ganglionic and lobar sites, primarily when leukoaraiosis is extensive and patients are treated with anticoagulants because of prior ischemic events. CONCLUSIONS:Leukoaraiosis shares with stroke common pathophysiological mechanisms and, because it is likely an expression of the same disease, must be regarded as an intermediate surrogate of stroke rather than a true stroke risk factor.
Authors: Curtis R French; Sudha Seshadri; Anita L Destefano; Myriam Fornage; Corey R Arnold; Philip J Gage; Jonathan M Skarie; William B Dobyns; Kathleen J Millen; Ting Liu; William Dietz; Tsutomu Kume; Marten Hofker; Derek J Emery; Sarah J Childs; Andrew J Waskiewicz; Ordan J Lehmann Journal: J Clin Invest Date: 2014-09-24 Impact factor: 14.808
Authors: Robert J Dawe; David A Bennett; Julie A Schneider; Sue E Leurgans; Aikaterini Kotrotsou; Patricia A Boyle; Konstantinos Arfanakis Journal: Neurobiol Aging Date: 2014-02-06 Impact factor: 4.673
Authors: Hyung-Min Kwon; Michael J Lynn; Tanya N Turan; Colin P Derdeyn; David Fiorella; Bethany F Lane; Jean Montgomery; L Scott Janis; Zoran Rumboldt; Marc I Chimowitz Journal: JAMA Neurol Date: 2016-01 Impact factor: 18.302
Authors: Marco Inzitari; Claudia Pozzi; Luigi Ferrucci; Daniela Chiarantini; Lucio A Rinaldi; Marco Baccini; Riccardo Pini; Giulio Masotti; Niccolò Marchionni; Mauro Di Bari Journal: Arch Intern Med Date: 2008-06-23
Authors: Domenico Inzitari; Giovanni Pracucci; Anna Poggesi; Giovanna Carlucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni Journal: BMJ Date: 2009-07-06